Insulet
PODD
#1015
Rank
$19.29 B
Marketcap
$275.10
Share price
-0.22%
Change (1 day)
68.04%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): $0.30 Billion USD

According to Insulet's latest financial reports the company's current earnings are $1.87 Billion USD. In 2023 the company made an earning of $0.25 Billion USD, an increase over its 2022 earnings that were of $43.1 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.30 B22.13%
2023 $0.25 B481.9%
2022 $43.1 M-45.24%
2021 $78.7 M43.35%
2020 $54.9 M18.51%
2019 $46.32 M41.16%
2018 $32.81 M-711.95%
2017 -$5.37 Million-56.85%
2016 -$12.43 Million-79.31%
2015 -$60.09 Million63.85%
2014 -$36.68 Million31.04%
2013 -$27.99 Million-21.96%
2012 -$35.87 Million
2010 -$34.21 Million-42.38%
2009 -$59.36 Million-33.56%
2008 -$89.35 Million65.93%
2007 -$53.85 Million209.75%
2006 -$17.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$7.34 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.14 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.76 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.39 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.77 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.64 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$10.15 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA